Skip to main content

Aequus Pharmaceuticals

Vancouver, Canada

Aequus Pharmaceuticals is a pharmaceutical company that focuses on therapeutic areas, including neurology, ophthalmology, and transplant.

$299K raised
Jul 2023
Post-IPO Debt

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aequus Pharmaceuticals

How much funding has Aequus Pharmaceuticals raised?
Aequus Pharmaceuticals has raised $299K in total funding. The most recent round was Post-IPO Debt. The last funding was announced in July 2023.
Who are Aequus Pharmaceuticals's investors?
Aequus Pharmaceuticals's investors include Northview LifeSciences.
Where is Aequus Pharmaceuticals headquartered?
Aequus Pharmaceuticals is headquartered in Vancouver, Canada.
What does Aequus Pharmaceuticals do?
Aequus Pharmaceuticals is a pharmaceutical company that focuses on therapeutic areas, including neurology, ophthalmology, and transplant.
What stage is Aequus Pharmaceuticals at?
Aequus Pharmaceuticals is at the Post-IPO Debt stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Aequus Pharmaceuticals — Funding & Investors." VCBacked, July 6, 2023, https://www.vcbacked.co/company/aequus-pharmaceuticals. Accessed July 3, 2026.
APA
VCBacked. (2023). Aequus Pharmaceuticals — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/aequus-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Aequus Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/aequus-pharmaceuticals |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .